Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Association analysis of 29,956 individuals confirms that a low- frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion
Author: Yaghootkar, H.
Stancáková, A.
Freathy, R.
Vangipurapu, J.
Weedon, M.
Xie, W.
Wood, A.
Ferrannini, E.
Mari, A.
Ring, S.
Lawlor, D.
Smith, G.
Jørgensen, T.
Hansen, T.
Pedersen, O.
Steinthorsdottir, V.
Guobjartsson, D.
Thorleifsson, G.
Thorsteinsdottir, U.
Stefansson, K.
et al.
Citation: Diabetes, 2015; 64(6):2279-2285
Publisher: American Diabetes Association
Issue Date: 2015
ISSN: 0012-1797
Statement of
Hanieh Yaghootkar ... Debbie A. Lawlor ... et al.
Abstract: A recent study identified a low-frequency variant at CCND2 associated with lower risk of type 2 diabetes, enhanced insulin response to a glucose challenge, higher height, and, paradoxically, higher BMI. We aimed to replicate the strength and effect size of these associations in independent samples and to assess the underlying mechanism. We genotyped the variant in 29,956 individuals and tested its association with type 2 diabetes and related traits. The low-frequency allele was associated with a lower risk of type 2 diabetes (OR 0.53; P = 2 3 10213; 6,647 case vs. 12,645 control subjects), higher disposition index (b = 0.07 log10; P = 2 3 10211; n = 13,028), and higher Matsuda index of insulin sensitivity (b = 0.02 log10; P = 5 3 1023; n = 13,118) but not fasting proinsulin (b = 0.01 log10; P = 0.5; n = 6,985). The low frequency allele was associated with higher adult height (b = 1.38 cm; P = 6 3 1029; n = 13,927), but the association of the variant with BMI (b = 0.36 kg/m2; P = 0.02; n = 24,807), estimated in four population-based samples, was less than in the original publication where the effect estimate was biased by analyzing case subjects with type 2 diabetes and control subjects without diabetes separately. Our study establishes that a low-frequency allele in CCND2 halves the risk of type 2 diabetes primarily through enhanced insulin secretion.
Keywords: Humans
Diabetes Mellitus, Type 2
Body Mass Index
Gene Frequency
Cyclin D2
Rights: © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
DOI: 10.2337/db14-1456
Grant ID: SP/07 1008/24066
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.